Markets

Market

News Details

(06/02/2026 19:10)

Anuh Pharma Q3 net profit up 30.08% at Rs 13.45 cr

The company reported standalone net profit of Rs 13.45 crore for the quarter ended December 31, 2025 as compared to Rs 10.34 crore in the same period last year, registering a year-on-year growth of 30.08 per cent.

Net revenue of the company rose substantially by 23.62 per cent at Rs 197.18 crore in October-December quarter of this fiscal as against Rs 159.51 crore in the corresponding period last year.

During October-December quarter, operating expenses increased by 24.64 per cent to Rs 180.38 crore from Rs 144.72 crore in year ago period.

Other Income grew by 337.23 per cent at Rs 4.11 crore versus (Dec'24 Rs 0.94 crore).

Operating Profit surged by 13.59 per cent to Rs 16.80 crore as against Rs 14.79 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 8.09 per cent in December quarter.

Interest declined by 71.43 per cent y-o-y to Rs 0.08 crore, while Taxation increased by 50.00 per cent at Rs 4.38 crore (Dec'24 Rs 2.92 crore).

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.